Virus replicon particles expressing porcine reproductive and respiratory syndrome virus proteins elicit immune priming but do not confer protection from viremia in pigs

[1]  Xiang‐Jin Meng,et al.  Live porcine reproductive and respiratory syndrome virus vaccines: Current status and future direction. , 2015, Vaccine.

[2]  Mingming Huang,et al.  Involvement of CD16 in antibody-dependent enhancement of porcine reproductive and respiratory syndrome virus infection. , 2015, The Journal of general virology.

[3]  K. Lager,et al.  Inactivated and subunit vaccines against porcine reproductive and respiratory syndrome: Current status and future direction. , 2015, Vaccine.

[4]  P. Jiang,et al.  The amino acid residues at 102 and 104 in GP5 of porcine reproductive and respiratory syndrome virus regulate viral neutralization susceptibility to the porcine serum neutralizing antibody. , 2015, Virus research.

[5]  M. Veit,et al.  Membrane proteins of arterivirus particles: Structure, topology, processing and function , 2014, Virus Research.

[6]  C. Sánchez,et al.  Antigenic structures stably expressed by recombinant TGEV-derived vectors , 2014, Virology.

[7]  G. Zimmer,et al.  Pseudotyping of vesicular stomatitis virus with the envelope glycoproteins of highly pathogenic avian influenza viruses. , 2014, The Journal of general virology.

[8]  G. Zimmer,et al.  Vesicular stomatitis virus replicon expressing the VP2 outer capsid protein of bluetongue virus serotype 8 induces complete protection of sheep against challenge infection , 2014, Veterinary Research.

[9]  C. Zhang,et al.  Porcine reproductive and respiratory syndrome virus vaccines: current status and strategies to a universal vaccine. , 2014, Transboundary and emerging diseases.

[10]  J. Kwang,et al.  A novel baculovirus vector shows efficient gene delivery of modified porcine reproductive and respiratory syndrome virus antigens and elicits specific immune response. , 2013, Vaccine.

[11]  H. Nauwynck,et al.  Pathogenesis and prevention of placental and transplacental porcine reproductive and respiratory syndrome virus infection , 2013, Veterinary Research.

[12]  M. Kikkert,et al.  Arterivirus molecular biology and pathogenesis. , 2013, The Journal of general virology.

[13]  Hsueh-Wei Chang,et al.  Recombinant chimeric vaccine composed of PRRSV antigens and truncated Pseudomonas exotoxin A (PE-K13). , 2013, Research in veterinary science.

[14]  W. Feng,et al.  CTLA4 mediated targeting enhances immunogenicity against PRRSV in a DNA prime/killed virus boost strategy. , 2013, Veterinary immunology and immunopathology.

[15]  T. Stadejek,et al.  Molecular evolution of PRRSV in Europe: current state of play. , 2013, Veterinary microbiology.

[16]  G. Zimmer,et al.  Vaccination with Recombinant RNA Replicon Particles Protects Chickens from H5N1 Highly Pathogenic Avian Influenza Virus , 2013, PloS one.

[17]  I. Díaz,et al.  Immunization with DNA vaccines containing porcine reproductive and respiratory syndrome virus open reading frames 5, 6, and 7 may be related to the exacerbation of clinical disease after an experimental challenge. , 2013, Viral immunology.

[18]  J. Rebel,et al.  Comparative analysis of immune responses following experimental infection of pigs with European porcine reproductive and respiratory syndrome virus strains of differing virulence , 2012, Veterinary Microbiology.

[19]  R. Rowland,et al.  Pathogenesis of porcine reproductive and respiratory syndrome virus. , 2012, Current opinion in virology.

[20]  W. Charerntantanakul.  Porcine reproductive and respiratory syndrome virus vaccines: Immunogenicity, efficacy and safety aspects. , 2012, World journal of virology.

[21]  Gaiping Zhang,et al.  Porcine FcγRIIb Mediates Enhancement of Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) Infection , 2011, PloS one.

[22]  G. Zimmer,et al.  A Vesicular Stomatitis Virus Replicon-Based Bioassay for the Rapid and Sensitive Determination of Multi-Species Type I Interferon , 2011, PloS one.

[23]  H. Nauwynck,et al.  Characterization of antigenic regions in the porcine reproductive and respiratory syndrome virus by the use of peptide-specific serum antibodies. , 2011, Vaccine.

[24]  M. Murtaugh,et al.  Novel structural protein in porcine reproductive and respiratory syndrome virus encoded by an alternative ORF5 present in all arteriviruses , 2011, The Journal of general virology.

[25]  J. F. Atkins,et al.  Discovery of a small arterivirus gene that overlaps the GP5 coding sequence and is important for virus production , 2011, The Journal of general virology.

[26]  P. Eckersall,et al.  Optimal combinations of acute phase proteins for detecting infectious disease in pigs , 2011, Veterinary research.

[27]  C. Prieto,et al.  Immunisation of pigs with a major envelope protein sub-unit vaccine against porcine reproductive and respiratory syndrome virus (PRRSV) results in enhanced clinical disease following experimental challenge , 2010, The Veterinary Journal.

[28]  S. Suradhat,et al.  Taming PRRSV: revisiting the control strategies and vaccine design. , 2010, Virus research.

[29]  H. Nauwynck,et al.  GP4-specific neutralizing antibodies might be a driving force in PRRSV evolution. , 2010, Virus research.

[30]  T. Lam,et al.  The ever-expanding diversity of porcine reproductive and respiratory syndrome virus. , 2010, Virus research.

[31]  I. Díaz,et al.  Certainties, doubts and hypotheses in porcine reproductive and respiratory syndrome virus immunobiology. , 2010, Virus research.

[32]  E. Loza-Rubio,et al.  Vaccine production in plant systems--an aid to the control of viral diseases in domestic animals: a review. , 2010, Acta veterinaria Hungarica.

[33]  J. Lunney,et al.  Porcine reproductive and respiratory syndrome virus: An update on an emerging and re-emerging viral disease of swine , 2010, Virus Research.

[34]  H. Nauwynck,et al.  A variable region in GP4 of European-type porcine reproductive and respiratory syndrome virus induces neutralizing antibodies against homologous but not heterologous virus strains. , 2010, Viral immunology.

[35]  Yao-Wei Huang,et al.  Novel strategies and approaches to develop the next generation of vaccines against porcine reproductive and respiratory syndrome virus (PRRSV) , 2010, Virus Research.

[36]  I. Sola,et al.  Vectored vaccines to protect against PRRSV , 2010, Virus Research.

[37]  T. A. Saveleva,et al.  Pathogenesis and antigenic characterization of a new East European subtype 3 porcine reproductive and respiratory syndrome virus isolate , 2010, BMC veterinary research.

[38]  Yanjun Zhou,et al.  Origin of Highly Pathogenic Porcine Reproductive and Respiratory Syndrome Virus, China , 2010, Emerging infectious diseases.

[39]  F. Osorio,et al.  The Minor Envelope Glycoproteins GP2a and GP4 of Porcine Reproductive and Respiratory Syndrome Virus Interact with the Receptor CD163 , 2009, Journal of Virology.

[40]  G. Zimmer,et al.  A recombinant vesicular stomatitis virus replicon vaccine protects chickens from highly pathogenic avian influenza virus (H7N1). , 2009, Vaccine.

[41]  Xinglong Wang,et al.  Enhanced immune responses of mice inoculated recombinant adenoviruses expressing GP5 by fusion with GP3 and/or GP4 of PRRS virus. , 2008, Virus research.

[42]  J. Rose,et al.  SARS vaccine based on a replication-defective recombinant vesicular stomatitis virus is more potent than one based on a replication-competent vector , 2008, Virology.

[43]  C. Prieto,et al.  Failure of an inactivated vaccine against porcine reproductive and respiratory syndrome to protect gilts against a heterologous challenge with prrsv , 2007, Veterinary Record.

[44]  Bin Zhou,et al.  Co-expressing GP5 and M proteins under different promoters in recombinant modified vaccinia virus ankara (rMVA)-based vaccine vector enhanced the humoral and cellular immune responses of porcine reproductive and respiratory syndrome virus (PRRSV) , 2007, Virus Genes.

[45]  G. Kobinger,et al.  Vesicular stomatitis virus vectors expressing avian influenza H5 HA induce cross-neutralizing antibodies and long-term protection. , 2007, Virology.

[46]  Huijun Lu,et al.  Immune responses of pigs inoculated with a recombinant fowlpox virus coexpressing GP5/GP3 of porcine reproductive and respiratory syndrome virus and swine IL-18. , 2007, Vaccine.

[47]  B. Li,et al.  Immunogenicity and protective efficacy of recombinant pseudorabies virus expressing the two major membrane-associated proteins of porcine reproductive and respiratory syndrome virus. , 2007, Vaccine.

[48]  M. Torremorell,et al.  Neutralizing antibody responses of pigs infected with natural GP5 N-glycan mutants of porcine reproductive and respiratory syndrome virus. , 2006, Viral immunology.

[49]  J. Ziebuhr,et al.  Nidovirales: Evolving the largest RNA virus genome , 2006, Virus Research.

[50]  P. Rottier,et al.  Envelope Protein Requirements for the Assembly of Infectious Virions of Porcine Reproductive and Respiratory Syndrome Virus , 2005, Journal of Virology.

[51]  Colin D. Johnson,et al.  Assessment of the economic impact of porcine reproductive and respiratory syndrome on swine production in the United States. , 2005, Journal of the American Veterinary Medical Association.

[52]  I. Díaz,et al.  Immune responses of pigs after experimental infection with a European strain of Porcine reproductive and respiratory syndrome virus. , 2005, The Journal of general virology.

[53]  C. Schwegmann-Wessels,et al.  Use of influenza C virus glycoprotein HEF for generation of vesicular stomatitis virus pseudotypes. , 2005, The Journal of general virology.

[54]  W. Chittick,et al.  Simultaneous Detection of North American and European Porcine Reproductive and Respiratory Syndrome Virus Using Real-Time Quantitative Reverse Transcriptase–PCR , 2005, Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc.

[55]  F. Osorio,et al.  Role of neutralizing antibodies in PRRSV protective immunity. , 2004, Veterinary immunology and immunopathology.

[56]  P. Plagemann.  The primary GP5 neutralization epitope of North American isolates of porcine reproductive and respiratory syndrome virus. , 2004, Veterinary immunology and immunopathology.

[57]  H. Nauwynck,et al.  Impact of genetic diversity of European-type porcine reproductive and respiratory syndrome virus strains on vaccine efficacy. , 2004, Vaccine.

[58]  K. Yoon,et al.  Monoclonal antibody analysis of Porcine Reproductive and Respiratory Syndrome virus epitopes associated with antibody-dependent enhancement and neutralization of virus infection , 2004, Veterinary Immunology and Immunopathology.

[59]  K. McCullough,et al.  Type‐A CpG oligonucleotides activate exclusively porcine natural interferon‐producing cells to secrete interferon‐α, tumour necrosis factor‐α and interleukin‐12 , 2004 .

[60]  K. McCullough,et al.  Type-A CpG oligonucleotides activate exclusively porcine natural interferon-producing cells to secrete interferon-alpha, tumour necrosis factor-alpha and interleukin-12. , 2004, Immunology.

[61]  Alicia Urniza,et al.  Baculovirus Expression of Proteins of Porcine Reproductive and Respiratory Syndrome Virus Strain Olot/91. Involvement of ORF3 and ORF5 Proteins in Protection , 2004, Virus Genes.

[62]  M. Murtaugh,et al.  Immunological responses of swine to porcine reproductive and respiratory syndrome virus infection. , 2002, Viral immunology.

[63]  M. Ostrowski,et al.  Identification of Neutralizing and Nonneutralizing Epitopes in the Porcine Reproductive and Respiratory Syndrome Virus GP5 Ectodomain , 2002, Journal of Virology.

[64]  J. Zimmerman,et al.  Categorization of North American porcine reproductive and respiratory syndrome viruses: Epitopic profiles of the N, M, GP5 and GP3 proteins and susceptibility to neutralization , 2000, Archives of Virology.

[65]  X. Meng,et al.  Heterogeneity of porcine reproductive and respiratory syndrome virus: implications for current vaccine efficacy and future vaccine development , 2000, Veterinary Microbiology.

[66]  K. Rossow.  Porcine Reproductive and Respiratory Syndrome , 1998, Veterinary pathology.

[67]  J. Meulenberg,et al.  Posttranslational processing and identification of a neutralization domain of the GP4 protein encoded by ORF4 of Lelystad virus , 1997, Journal of virology.

[68]  S. Dea,et al.  Intracellular synthesis, processing, and transport of proteins encoded by ORFs 5 to 7 of porcine reproductive and respiratory syndrome virus. , 1996, Virology.

[69]  J. Zimmerman,et al.  Antibody-dependent enhancement (ADE) of porcine reproductive and respiratory syndrome virus (PRRSV) infection in pigs. , 1996, Viral immunology.